Danske Bank’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Danske Bank's UNCY Position: Q3 2026 in Review
Danske Bank held its Unicycive Therapeutics (UNCY) position steady in Q3 2026 at 1 share worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #1091.
Danske Bank first reported a position in UNCY in Q2 2025 and has held it in 6 quarters since. The position peaked at $7 in Q1 2026. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Danske Bank held 1 share of Unicycive Therapeutics worth $5 as of Q3 2026.
- Danske Bank left its Unicycive Therapeutics share count unchanged in Q3 2026.
- Unicycive Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1091 holding.
- Danske Bank first reported a position in Unicycive Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Danske Bank's Unicycive Therapeutics position peaked at $7 in Q1 2026.
- 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.